Abstract
The rapid diffusion of screening interventions that have the ability to detect latent asymptomatic disease leads to important concerns regarding costs and patient quality of life for men aged 65 years and older. Geographic variability in the adoption of PSA testing underscores uncertainty and disagreement about its value for reducing prostate cancer mortality. More research is required to determine the effectiveness of screening for prostate cancer.
Keywords
MedicineProstate cancerProstateIncidence (geometry)PopulationEpidemiologyCancerTransurethral resection of the prostateCancer registryGynecologyDemographyUrologyInternal medicineEnvironmental health
MeSH Terms
Age DistributionAgedBiopsyNeedleHumansIncidenceMaleMass ScreeningProstate-Specific AntigenProstatic NeoplasmsSEER ProgramUltrasonographyUnited States
Affiliated Institutions
Related Publications
Trends in Prostate-Specific Antigen Testing From 1995 Through 2004
In a nationally representative sample, we found that despite the lack of clear evidence of benefit, PSA testing for prostate cancer screening has increased dramatically, especia...
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Abstract This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the Inter...
Cancer Statistics, 2009
Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on...
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women
Abstract Introduction A recent abstract presented in a breast cancer symposium attributed the sharp decrease in female breast cancer incidence rates from 2002 to 2003 in the Sur...
Annual report to the nation on the status of cancer, 1975–2004, featuring cancer in American Indians and Alaska Natives
Abstract BACKGROUND. The American Cancer Society, the Centers for Disease Control and Prevention, the National Cancer Institute, and the North American Association of Central Ca...
Publication Info
- Year
- 1995
- Type
- article
- Volume
- 273
- Issue
- 7
- Pages
- 548-548
- Citations
- 659
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
659
OpenAlex
14
Influential
522
CrossRef
Cite This
Arnold L. Potosky
(1995).
The Role of Increasing Detection in the Rising Incidence of Prostate Cancer.
JAMA
, 273
(7)
, 548-548.
https://doi.org/10.1001/jama.1995.03520310046028
Identifiers
- DOI
- 10.1001/jama.1995.03520310046028
- PMID
- 7530782